What is Solid Biosciences LLC (SLDB) stock price today?

Solid Biosciences LLC (SLDB) currently trades at $7.26 per share. The stock has a market capitalization of $733.18M and a P/E ratio of —x.

Is SLDB stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Solid Biosciences LLC has a Smart Value Score of 29/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 1/9 and Altman Z-Score is -6.54.

Is Solid Biosciences LLC financially healthy?

Solid Biosciences LLC's Piotroski F-Score is 1/9 (weak financial health). The Altman Z-Score of -6.54 places it in the distress.

SLDB

Solid Biosciences LLC

NASDAQ: SLDB · HEALTHCARE · BIOTECHNOLOGY

$7.26

+2.98% today

Updated 2026-04-30

Market cap

$733.18M

P/E ratio

—

P/S ratio

3.65x

EPS (TTM)

$-1.99

Dividend yield

—

52W range

$2 – $9

Volume

1.3M

Market cap

$733.18M

P/E ratio

—

P/S ratio

3.65x

EPS (TTM)

$-1.99

Dividend yield

—

52W range

$2 – $9

Volume

1.3M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

6.0

Quality

3.0

Profitability

5.0

Valuation

C+

1/9

Piotroski F-Score

Weak

-6.5

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$17.08

+135.26%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

4 Strong Buy9 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.10x — low leverage

Risks

- Piotroski 1/9 — weak financial health

- Altman Z -6.54 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-54.12M

- Revenue declining -100.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$8.09M	$0.00	$0.00	$0.00	$0.00
Net income	$-85.98M	$-96.02M	$-124.70M	$-174.32M	$-49.79M
EPS	—	—	—	—	$-1.99
Free cash flow	$-100.99M	$-95.69M	$-100.67M	$-157.44M	$-54.12M
Profit margin	-1,062.28%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SLDB	$733.18M	29	3.7	3.0	5.0	6.0	—	Avoid
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Solid Biosciences LLC trades at $7.26. Our Smart Value Score of 29/100 indicates the stock is weak. The company scores 1/9 on the Piotroski F-Score. With an Altman Z-Score of -6.54, it sits in the distress.

Frequently asked questions

What is Solid Biosciences LLC's stock price?

Solid Biosciences LLC (SLDB) trades at $7.26.

Is Solid Biosciences LLC overvalued?

Smart Value Score 29/100 (Grade F, Strong Sell).

What is the price target of Solid Biosciences LLC (SLDB)?

The analyst target price is $17.08, representing +135.3% upside from the current price of $7.26.

Piotroski F-Score?

1/9 — weak financial health.

Altman Z-Score?

-6.54 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.solidbio.com

Quick metrics

P/S ratio3.65x

ROE-109.90%

Beta2.58

50D MA$7.24

200D MA$6.12

Shares out0.10B

Float0.06B

Short ratio—

Avg volume1.3M

Performance

1 week-14.23%

1 month-2.08%

3 months+6.82%

YTD+25.00%

1 year—

3 years—

5 years—

Compare

SLDB vs LLY →SLDB vs JNJ →SLDB vs ABBV →Stock screener →